12-100311187-A-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_017988.6(SCYL2):c.624A>T(p.Glu208Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000296 in 1,586,578 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_017988.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SCYL2 | ENST00000360820.7 | c.624A>T | p.Glu208Asp | missense_variant | Exon 5 of 18 | 1 | NM_017988.6 | ENSP00000354061.2 | ||
SCYL2 | ENST00000635101.1 | c.624A>T | p.Glu208Asp | missense_variant | Exon 5 of 19 | 5 | ENSP00000489123.1 | |||
SCYL2 | ENST00000549687.5 | c.624A>T | p.Glu208Asp | missense_variant | Exon 5 of 17 | 2 | ENSP00000448366.1 | |||
SCYL2 | ENST00000548392.5 | c.105A>T | p.Glu35Asp | missense_variant | Exon 4 of 5 | 4 | ENSP00000450294.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152190Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000133 AC: 3AN: 224876Hom.: 0 AF XY: 0.00000820 AC XY: 1AN XY: 121960
GnomAD4 exome AF: 0.0000321 AC: 46AN: 1434388Hom.: 0 Cov.: 30 AF XY: 0.0000280 AC XY: 20AN XY: 713188
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152190Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74342
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.624A>T (p.E208D) alteration is located in exon 5 (coding exon 4) of the SCYL2 gene. This alteration results from a A to T substitution at nucleotide position 624, causing the glutamic acid (E) at amino acid position 208 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at